With so much going on in the city’s thriving ecosystem, it is easy to miss some of the happenings in the space. We keep you abreast of a few of things that you may have missed in NYC Tech News this week including the fundings, exits, and events. CLICK HERE TO SEE WHAT HAPPENED IN NYC […]
Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. Founded by Angela Koehler in 2017, Kronos Bio is backed by investors that include GV, Invus, Perceptive Advisors, Polaris Partners, and Vida Ventures and is headquartered in New York, New York.